JAZZ — Jazz Pharmaceuticals plc
In 2026 Q2, 8 of the 140 tracked hedge funds reported a position in Jazz Pharmaceuticals plc (JAZZ), worth $166.37M combined. Over the quarter 2 opened or added, 5 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $135.44M | 0.19% | -31.4% |
| VanEck | $10.10M | 0.00% | -22.2% |
| Ardsley | $7.23M | 0.78% | NEW |
| Essex | $5.22M | 0.68% | -0.5% |
| Quadrature | $4.06M | 0.03% | +116.1% |
| CastleKnight | $2.87M | 0.10% | NO CHANGE |
| Kohlberg | $1.17M | 0.02% | -53.1% |
| Persistent | $280.49K | 0.09% | -92.7% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.